- Home
- RWAY vs BNTC Comparison
RWAY vs BNTC Comparison
Compare RWAY & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- BNTC
- Stock Information
- Founded
- RWAY 2015
- BNTC 1995
- Country
- RWAY United States
- BNTC United States
- Employees
- RWAY N/A
- BNTC N/A
- Industry
- RWAY
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- RWAY
- BNTC Health Care
- Exchange
- RWAY Nasdaq
- BNTC Nasdaq
- Market Cap
- RWAY 410.4M
- BNTC 365.1M
- IPO Year
- RWAY 2021
- BNTC N/A
- Fundamental
- Price
- RWAY $9.86
- BNTC $13.40
- Analyst Decision
- RWAY Buy
- BNTC Strong Buy
- Analyst Count
- RWAY 6
- BNTC 5
- Target Price
- RWAY $11.17
- BNTC $26.60
- AVG Volume (30 Days)
- RWAY 294.8K
- BNTC 240.4K
- Earning Date
- RWAY 11-06-2025
- BNTC 11-12-2025
- Dividend Yield
- RWAY 14.26%
- BNTC N/A
- EPS Growth
- RWAY 45.28
- BNTC N/A
- EPS
- RWAY 1.48
- BNTC N/A
- Revenue
- RWAY $141,071,000.00
- BNTC N/A
- Revenue This Year
- RWAY N/A
- BNTC N/A
- Revenue Next Year
- RWAY N/A
- BNTC N/A
- P/E Ratio
- RWAY $6.62
- BNTC N/A
- Revenue Growth
- RWAY N/A
- BNTC N/A
- 52 Week Low
- RWAY $8.35
- BNTC $9.10
- 52 Week High
- RWAY $11.73
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- RWAY 45.22
- BNTC 41.68
- Support Level
- RWAY $9.42
- BNTC $11.54
- Resistance Level
- RWAY $9.96
- BNTC $15.86
- Average True Range (ATR)
- RWAY 0.21
- BNTC 1.31
- MACD
- RWAY 0.01
- BNTC -0.43
- Stochastic Oscillator
- RWAY 53.21
- BNTC 37.80
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.